These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 29522202)

  • 1. Natural History of Established and De Novo Inflammatory Bowel Disease After Liver Transplantation for Primary Sclerosing Cholangitis.
    Mouchli MA; Singh S; Boardman L; Bruining DH; Lightner AL; Rosen CB; Heimbach JK; Hasan B; Poterucha JJ; Watt KD; Kane SV; Raffals LE; Loftus EV
    Inflamm Bowel Dis; 2018 Apr; 24(5):1074-1081. PubMed ID: 29522202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis.
    Singh S; Loftus EV; Talwalkar JA
    Am J Gastroenterol; 2013 Sep; 108(9):1417-25. PubMed ID: 23896954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of inflammatory bowel disease post-liver transplantation for primary sclerosing cholangitis.
    Joshi D; Bjarnason I; Belgaumkar A; O'Grady J; Suddle A; Heneghan MA; Aluvihare V; Rela M; Heaton N; Agarwal K
    Liver Int; 2013 Jan; 33(1):53-61. PubMed ID: 22103794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colorectal cancer in patients with inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis.
    Vera A; Gunson BK; Ussatoff V; Nightingale P; Candinas D; Radley S; Mayer A; Buckels JA; McMaster P; Neuberger J; Mirza DF
    Transplantation; 2003 Jun; 75(12):1983-8. PubMed ID: 12829898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Asymptomatic De Novo Inflammatory Bowel Disease Late After Liver Transplantation for Primary Sclerosing Cholangitis: A Case Report.
    Åberg F; Abdulle A; Mäkelä A; Nissinen M
    Transplant Proc; 2015 Nov; 47(9):2775-7. PubMed ID: 26680092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunosuppression after liver transplantation for primary sclerosing cholangitis influences activity of inflammatory bowel disease.
    Jørgensen KK; Lindström L; Cvancarova M; Karlsen TH; Castedal M; Friman S; Schrumpf E; Foss A; Isoniemi H; Nordin A; Holte K; Rasmussen A; Bergquist A; Vatn MH; Boberg KM
    Clin Gastroenterol Hepatol; 2013 May; 11(5):517-23. PubMed ID: 23333218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of colorectal cancer after liver transplantation for primary sclerosing cholangitis: a systematic review and meta-analysis.
    Singh S; Edakkanambeth Varayil J; Loftus EV; Talwalkar JA
    Liver Transpl; 2013 Dec; 19(12):1361-9. PubMed ID: 24019127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical management of inflammatory bowel disease in the organ recipient.
    Indriolo A; Ravelli P
    World J Gastroenterol; 2014 Apr; 20(13):3525-33. PubMed ID: 24707135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activity of Inflammatory Bowel Disease After Liver Transplantation for Primary Sclerosing Cholangitis Predicts Poorer Clinical Outcomes.
    Peverelle M; Paleri S; Hughes J; De Cruz P; Gow PJ
    Inflamm Bowel Dis; 2020 Nov; 26(12):1901-1908. PubMed ID: 31944235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk Factors and Outcomes of De Novo Cancers (Excluding Nonmelanoma Skin Cancer) After Liver Transplantation for Primary Sclerosing Cholangitis.
    Mouchli MA; Singh S; Loftus EV; Boardman L; Talwalkar J; Rosen CB; Heimbach JK; Wiesner RH; Hasan B; Poterucha JJ; Kymberly WD
    Transplantation; 2017 Aug; 101(8):1859-1866. PubMed ID: 28272287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of colonic neoplasia after liver transplantation for primary sclerosing cholangitis.
    Hanouneh IA; Macaron C; Lopez R; Zein NN; Lashner BA
    Inflamm Bowel Dis; 2012 Feb; 18(2):269-74. PubMed ID: 21425212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammatory bowel disease in liver transplanted patients.
    Filipec Kanizaj T; Mijic M
    World J Gastroenterol; 2017 May; 23(18):3214-3227. PubMed ID: 28566881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammatory bowel disease after liver transplantation: risk factors for recurrence and de novo disease.
    Verdonk RC; Dijkstra G; Haagsma EB; Shostrom VK; Van den Berg AP; Kleibeuker JH; Langnas AN; Sudan DL
    Am J Transplant; 2006 Jun; 6(6):1422-9. PubMed ID: 16686766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical course and management of inflammatory bowel disease after liver transplantation.
    Befeler AS; Lissoos TW; Schiano TD; Conjeevaram H; Dasgupta KA; Millis JM; Newell KA; Thistlethwaite JR; Baker AL
    Transplantation; 1998 Feb; 65(3):393-6. PubMed ID: 9484758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology and outcomes of primary sclerosing cholangitis with and without inflammatory bowel disease in an Australian cohort.
    Liu K; Wang R; Kariyawasam V; Wells M; Strasser SI; McCaughan G; Corte C; Leong RW
    Liver Int; 2017 Mar; 37(3):442-448. PubMed ID: 27891750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Preexisting Inflammatory Bowel Disease on the Outcome of Liver Transplantation for Primary Sclerosing Cholangitis.
    Irlès-Depé M; Roullet S; Neau-Cransac M; Dumortier J; Dharancy S; Houssel-Debry P; Boillot O; Chiche L; Laurent C; Laharie D; De Lédinghen V
    Liver Transpl; 2020 Nov; 26(11):1477-1491. PubMed ID: 32603007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness and safety of anti-TNF therapy for inflammatory bowel disease in liver transplant recipients for primary sclerosing cholangitis: A nationwide case series.
    Altwegg R; Combes R; Laharie D; De Ledinghen V; Radenne S; Conti F; Chazouilleres O; Duvoux C; Dumortier J; Leroy V; Treton X; Durand F; Dharancy S; Nachury M; Goutorbe F; Lamblin G; Boivineau L; Peyrin-Biroulet L; Pageaux GP
    Dig Liver Dis; 2018 Jul; 50(7):668-674. PubMed ID: 29655972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of colectomy in preventing recurrent primary sclerosing cholangitis in liver transplant recipients.
    Buchholz BM; Lykoudis PM; Ravikumar R; Pollok JM; Fusai GK
    World J Gastroenterol; 2018 Jul; 24(28):3171-3180. PubMed ID: 30065563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colorectal neoplasia in patients with primary sclerosing cholangitis undergoing liver transplantation: a Nordic multicenter study.
    Jørgensen KK; Lindström L; Cvancarova M; Castedal M; Friman S; Schrumpf E; Foss A; Isoniemi H; Nordin A; Holte K; Rasmussen A; Bergquist A; Vatn MH; Boberg KM
    Scand J Gastroenterol; 2012 Sep; 47(8-9):1021-9. PubMed ID: 22577871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinctive inflammatory bowel disease phenotype in primary sclerosing cholangitis.
    de Vries AB; Janse M; Blokzijl H; Weersma RK
    World J Gastroenterol; 2015 Feb; 21(6):1956-71. PubMed ID: 25684965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.